Deep dermal fibroblasts contribute to hypertrophic scarring

Laboratory Investigation

Volumn 88, Issue 12, 2008, Pages 1278-1290

  Wang, Jianfei ^a   Dodd, Carole ^a   Shankowsky, Heather A ^a   Scott, Paul G ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Collagen; Dermal depth; Fibroblast; HTS; Proteoglycan; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGENASE; CONNECTIVE TISSUE GROWTH FACTOR; DECORIN; HEAT SHOCK PROTEIN 47; MESSENGER RNA; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; VERSICAN;

ADULT; ARTICLE; CELL ISOLATION; DERMATOME; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; MALE; MASS SPECTROMETRY; NORTHERN BLOTTING; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELL SEPARATION; CELL SIZE; CHILD, PRESCHOOL; CICATRIX, HYPERTROPHIC; COLLAGENASES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 56649102305     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.101     Document Type: Article

References (62)

1. Scott PG, Ghahary A, Tredget EE. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 2000;16:271-287.
2. Tredget EE. Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann NY Acad Sci 1999;888:165-182.
3. Scott PG, Ghahary A, Wang JF, et al. Molecular and Cellular Hypertrophic Scarring. Saunders Elsevier Inc., Philadelphia, 2007, pp 596-607.
4. Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J Cell Sci 2004;117:667-675.
5. Sorrell JM, Baber MA, Caplan AI. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 2004;200:134-145.
6. Bressler RS, Bressler CH. Functional anatomy of the skin. Clin Podiatr Med Surg 1989;6:229-246.
7. Reynolds AJ, Jahoda CA. Inductive properties of hair follicle cells. Ann NY Acad Sci 1991;642:226-241; discussion 241-222.
8. Harper RA, Grove G. Human skin fibroblasts derived from papillary and reticular dermis: differences in growth potential in vitro. Science 1979;204:526-527.
9. Azzarone B, Macieira-Coelho A. Heterogeneity of the kinetics of proliferation within human skin fibroblastic cell populations. J Cell Sci 1982;57:177-187.
10. Schafer IA, Pandy M, Ferguson R, et al. Comparative observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: growth kinetics, packing density at confluence and surface morphology. Mech Ageing Dev 1985;31:275-293.
11. Jahoda CA, Reynolds AJ. Dermal-epidermal interactions. Adult follicle-derived cell populations and hair growth. Dermatol Clin 1996;14:573-583.
12. Ali-Bahar M, Bauer B, Tredget EE, et al. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 2004;12:175-182.
13. Sorrell JM, Baber MA, Caplan AI. Clonal characterization of fibroblasts in the superficial layer of the adult human dermis. Cell Tissue Res 2007;327:499-510.
14. Ross EV, Naseef GS, McKinlay JR, et al. Comparison of carbon dioxide laser, erbium:YAG laser, dermabrasion, and dermatome: a study of thermal damage, wound contraction, and wound healing in a live pig model: implications for skin resurfacing. J Am Acad Dermatol 2000;42:92-105.
15. Seukeran DC, Collins P, Sheehan-Dare RA. Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients. Br J Dermatol 1997;136:725-729.
16. Cuttle L, Kempf M, Phillips GE, et al. A porcine deep dermal partial thickness burn model with hypertrophic scarring. Burns 2006;32:806-820.
17. Dunkin CS, Pleat JM, Gillespie PH, et al. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 2007;119:1722-1732; discussion 1733-1724.
18. Ghahary A, Shen Q, Shen YJ, et al. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 1998;174:301-309.
19. Ghahary A, Shen YJ, Nedelec B, et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995;148:25-32.
20. Wang J, Jiao H, Stewart TL, et al. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 2007;15:530-539.
21. Scott PG, Goldberg HA. Cleavage of the carboxy-terminal cross-linking region of type I collagen by proteolytic activity from cultured porcine gingival explants. Coll Relat Res 1983;3:295-304.
22. Ghahary A, Marcoux Y, Karimi-Busheri F, et al. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005;124:170-177.
23. Sarkhosh K, Tredget EE, Li Y, et al. Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-gamma-treated skin cells in a co-culture system. Wound Repair Regen 2003;11:337-345.
24. Wang J, Jiao H, Stewart TL, et al. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol 2007;82:1554-1563.
25. Wang JF, Jiao H, Stewart TL, et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 2007;15:113-121.
26. Yang L, Chan T, Demare J, et al. Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis. Am J Pathol 2001;159:2147-2157.
27. Brigstock DR. The CCN family: a new stimulus package. J Endocrinol 2003;178:169-175.
28. Ghahary A, Shen YJ, Nedelec B, et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 1996;106:476-481.
29. Nagata K. Hsp47: a collagen-specific molecular chaperone. Trends Biochem Sci 1996;21:22-26.
30. Ishida Y, Kubota H, Yamamoto A, et al. Type I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesis. Mol Biol Cell 2006;17:2346-2355.
31. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol 2007;170:1807-1816.
32. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-537.
33. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007;257:143-179.
34. Scott PG, Dodd CM, Ghahary A, et al. Fibroblasts from post-burn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts. Clin Sci (Lond) 1998;94:541-547.
35. Lebaron RG. Versican. Perspect Dev Neurobiol 1996;3:261-271.
36. Thomas GJ, Bayliss MT, Harper K, et al. Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. Biochem J 1994;302(Part 1):49-56.
37. Wang JF, Olson ME, Reno CR, et al. Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 2000;41:195-211.
38. Bellemare J, Roberge CJ, Bergeron D, et al. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 2005;206:1-8.
39. Yang L, Scott PG, Giuffre J, et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-1192.
40. Tredget EE, Yang L, Delehanty M, et al. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 2006;26:179-189.
41. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14:23-42.
42. Ghahary A, Shen YJ, Scott PG, et al. Expression of mRNA for transforming growth factor-beta 1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passage in vitro. J Invest Dermatol 1994;103:684-686.
43. Van Obberghen-Schilling E, Roche NS, Flanders KC, et al. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-7746.
44. Wang R, Ghahary A, Shen Q, et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000;8:128-137.
45. Wang JF, Olson ME, Reno CR, et al. The pig as a model for excisional skin wound healing: characterization of the molecular and cellular biology, and bacteriology of the healing process. Comp Med 2001;51:341-348.
46. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003;81:355-363.
47. Wang JF, Olson ME, Ball DK, et al. Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen 2003;11:220-229.
48. Colwell AS, Phan TT, Kong W, et al. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 2005;116:1387-1390; discussion 1391-1382.
49. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005;13:7-12.
50. Pinnell SR. Regulation of collagen synthesis. J Invest Dermatol 1982;79(Suppl 1):73s-76s.
51. Rudolph R. Wide spread scars, hypertrophic scars, and keloids. Clin Plast Surg 1987;14:253-260.
52. Cohen IK. Can collagen metabolism be controlled: theoretical considerations. J Trauma 1985;25:410-412.
53. Diegelmann RF, Cohen IK, McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979;98:341-346.
54. Scott PG, Dodd CM, Tredget EE, et al. Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin Sci (Lond) 1996;90:417-425.
55. Schneider EL, Mitsui Y, Au KS, et al. Tissue-specific differences in cultured human diploid fibroblasts. Exp Cell Res 1977;108:1-6.
56. Narayanan AS, Page RC. Serum modulates collagen types in human gingiva fibroblasts. FEBS Lett 1977;80:221-224.
57. Botstein GR, Sherer GK, Leroy EC. Fibroblast selection in scleroderma. An alternative model of fibrosis. Arthritis Rheum 1982;25:189-195.
58. Borrello MA, Phipps RP. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol 1996;173:198-206.
59. Silvera MR, Phipps RP. Synthesis of interleukin-1 receptor antagonist by Thy-1+ and Thy-1- murine lung fibroblast subsets. J Interferon Cytokine Res 1995;15:63-70.
60. Phipps RP, Penney DP, Keng P, et al. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol 1989;1:65-74.
61. Mitsui Y, Schneider EL. Increased nuclear sizes in senescent human diploid fibroblast cultures. Exp Cell Res 1976;100:147-152.
62. Mitsui Y, Schneider EL. Characterization of fractionated human diploid fibroblast cell populations. Exp Cell Res 1976;103:23-30.